HTA30 An Irish Retrospective Analysis of Oncology Reimbursement Applications Considered by HSE Drugs Group 2022-2024
Abstract
Authors
Kevin T. Morris Hafizh A. Boenjamin Glenn Kelly
Kevin T. Morris Hafizh A. Boenjamin Glenn Kelly
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now